No penny stock discussions, including OTC, microcaps, pump & dumps, low vol pumps and SPACs. Non-ETF-related Crypto goes on r/CryptoCurrencies info. No bitcoin or crypto discussions unrelated to stocks. Trolling, insults, or harassment, especially in posts requesting advice, will be removed. Posts regarding this topic will be automatically removed.
The Robinhood app should be discussed in /r/Robinhood. Low effort mentions for meme stocks will be removed, see here. Instead, advertise here.Ĭontext & effort must be provided empty posts or empty posts with links will be automatically removed. Spam, ads, solicitations (including referral links), and self-promotion posts or comments will be removed and you might get banned. Rules (in depth rules wiki here)ĭisclose any related open positions when discussing a particular stock or financial instrument.
Linkdoc china plus#
**See The Wall Street Journal and other headlines on July 8, 2021, plus check out the “Risk Factors” in the company’s amended prospectus – F-1/A filing – dated July 7, 2021.Almost any post related to stocks is welcome please read the rules below:Ĭlick here to find how many days old your account needs to be and how much karma you need before you can comment or post to r/Stocks. (Note: LinkDoc Technology postponed its IPO early on Thursday, July 8, 2021, ahead of its scheduled pricing that night for a July 9 trade date, amid the Chinese government’s increasing regulatory scrutiny of Chinese companies going public in the U.S. dollars for 2020, according to the prospectus. Note: Revenue and net loss figures are in U.S.
Linkdoc china full#
Through these touchpoints, we also collect, with patient consent, full longitudinal patient data with outcomes, which then becomes part of the input into our continuous care platform and our LinkData System.
These patient care centers provide patients access to innovative therapeutic solutions and medication services and serve as a point of patient engagement with our digital continuous care platform. Our platform has become the largest oncology patient-centric continuous care platform in China, according to Frost & Sullivan.Īs part of our digital continuous care platform, we have also built a growing nationwide network of 34 patient care centers as of March 31, 2021, increasing from 24 in the beginning of 2019, covering 28 provinces.
Since April 2015, we have cumulatively cared for over 3.5 million patients and provided longitudinal care for over 2.5 million patients. We conduct personalized follow-up care through our call centers and online channels, and allow patients to consult physicians online via our Internet hospital and receive personalized disease management services. Working with healthcare providers and life sciences companies, we have conducted a large-scale multi-center retrospective study with a sample of 10,000 Chinese lung cancer patients, which demonstrated that our LinkCare Platform has improved patients’ survival rates meaningfully.
Linkdoc china Offline#
The platform integrates online and offline channels to help patients, especially those who suffer from cancer, better manage their illnesses as a chronic condition in and out of hospital. LinkCare Platform is a patient-centric digital continuous care platform for patients with critical diseases. We have successfully built China’s largest data-driven digital infrastructure for precision medicine, according to Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption. We are a leading data-driven and AI-enabled healthcare technology company in terms of being a first mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan.
0 kommentar(er)
